Predictive oncology stock.

Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35... Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued.Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country. Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35... Overview Press Releases Events & Presentations Financials & Filings Stock Quote & Chart Corporate Governance Contact Us Stock Quote (POAI) NASDAQ CM: POAI $3.17 Oct 2, 2023 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $3.17 Today's High $3.20 Today's Low $3.07 52 Week High $13.88 52 Week Low $2.47 Stock Chart

According to About.com, the fate of the children born on Wednesday in the poem “Monday’s Child” is that the child is full of woe. This poem was first written in 1838, but it is not believed that people ever really put much stock into its pr...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ...Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.

Predictive Oncology Inc. 91 43rd Street. Suite 110. Pittsburgh, Pennsylvania 15201. Phone 1 412 432-15000. Industry Medical Equipment/Supplies. Sector Health Care/Life Sciences. Effective March 16, 2023, Predictive Oncology and Cancer Research Horizons, the world’s largest private funder of cancer research, have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL platform that pairs artificial intelligence (AI) with the world’s largest biobank of tumor samples;Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ...The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...The estimated Net Worth of Daniel E Handley is at least $351 Thousand dollars as of 15 December 2022. Daniel Handley owns over 6,000 units of Predictive Oncology stock worth over $350,584 and over the last 3 years he sold POAI stock worth over $0. In addition, he makes $0 as Director at Predictive Oncology.

The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …

Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ...

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today …Stay informed on POAI stock price history, news, and more at Stocks Telegraph. Get the latest updates on Predictive Oncology for smart investing.Jun 13, 2023 · Predictive Oncology (POAI) Predictive Oncology (NASDAQ: POAI) is the first of the best tech-based penny stocks to consider. Cancer research has come a long way and yet it still has so far to go ... Here are three top AI stocks trading under $10 a share. Lantern Pharma Inc. ( LTRN ): A small, potential game-changer in the fight against cancer. Predictive Oncology (POAI): While risky, POAI ...

PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with UPMC Magee-Womens Hospital. The objective of the study was to evaluate the use of AI to build multi-omic machine learning (ML) models …EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...According to the issued ratings of 5 analysts in the last year, the consensus rating for Pyxis Oncology stock is Buy based on the current 5 buy ratings for PYXS. The average twelve-month price prediction for Pyxis Oncology is $8.33 with a high price target of $14.00 and a low price target of $4.00. Learn more on PYXS's analyst rating history.Predictive Oncology Inc. Weekly Stock List Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The third-quarter earnings season is ...He oversees Predictive Oncology’s solubility and stability contracts for numerous pharmaceutical/biotech companies. From 1981 to 2016, Dr. DeLucas was a faculty member at the University of Alabama at Birmingham (UAB) where he served as a Professor in the School of Optometry, Senior Scientist and Director of the Comprehensive Cancer Center X ... On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334.

Predictive Oncology Inc. 91 43rd Street. Suite 110. Pittsburgh, Pennsylvania 15201. Phone 1 412 432-15000. Industry Medical Equipment/Supplies. Sector Health Care/Life Sciences.

The estimated Net Worth of J Melville Engle is at least $117 millier dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $113,900 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.The estimated Net Worth of Richard L Gabriel is at least $7.57 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $5,234 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.Amesite Inc. (NASDAQ:AMST) posted its earnings results on Monday, November, 13th. The company reported ($0.35) EPS for the quarter. The company earned $0.06 million during the quarter. Amesite had a negative trailing twelve-month return on equity of 52.99% and a negative net margin of 552.07%.About Predictive Oncology (NASDAQ: POAI) The leading edge of a new frontier in drug discovery As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to … About us Read More »Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...Feb 24, 2021 · Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ... Nov 8, 2023 · Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ... Predictive Oncology Inc (NASDAQ:POAI) 3.22 Delayed Data As of 4:00pm ET +0.13 / +4.21% Today’s Change 2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date …

The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...

What this means: Predictive Oncology Inc (POAI) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives POAI a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. POAI rank of 10 means that it ranks below 90% of stocks.

The estimated Net Worth of J Melville Engle is at least $70.1 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $67,120 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.1 equities research analysts have issued 1-year target prices for Cardiff Oncology's stock. Their CRDF share price targets range from $13.00 to $13.00. On average, they expect the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 956.9% from the stock's current price.Predictive Oncology Inc. Watch list After Hours Last Updated: Nov 13, 2023 7:52 p.m. EST Delayed quote $ 3.0500 -0.14 -4.39% After Hours Volume: 35 Advanced …Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …The NFL’s preseason’s about to start, and that means regular season games will be kicking off before we know it. And since we all love to predict the future way before it really makes sense to do so, it feels like a great time to take stock...Oncology Pharma Inc () Stock Market info Recommendations: Buy or sell Oncology Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncology Pharma share forecasts, stock quote and buy / sell signals below.According to present data Oncology Pharma's ONPH shares and potentially its …Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022The estimated Net Worth of J Melville Engle is at least $60 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $56,950 and over the last 13 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.२०२३ नोभेम्बर ७ ... Predictive Oncology (NASDAQ: POAI), a science-driven company ... Stock Quotes. Get quotes for stocks: To display multiple quotes,enter ...Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ...Nov 16, 2023 · PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERS Get Predictive Oncology Inc (POAI.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInstagram:https://instagram. who owns olukaiangstrom technologiesotcmkts rmhbwhat is dow futures What's Thomas Goldrick's mailing address? Thomas's mailing address filed with the SEC is 2915 COMMERS DRIVE, SUITE 900, , EAGAN, MN, 55121. jepi reviewsbarron login Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive … accredited investors opportunities View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ...